Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator

References

• Barton DP, Cai A, Wendt K, Young M, Gamero A, De Cesare S (1997): Angiogenic protein expression in advanced epithelial ovarian cancer. Clin Cancer Res 3: 1579–1586.
   PubMed Web of Science ®Google Scholar
• Cai Z, Li YF, Liu FY (2007): Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer. Ai Zheng 26: 312–317.
   PubMedGoogle Scholar
• Collen D (1999): The plasminogen (fibrinolytic) system. Thromb Haemost 82: 259–270.
   PubMed Web of Science ®Google Scholar
• Danø K, Behrendt N, Høyer-Hansen G (2005): Plasminogen activation and cancer. Thromb Haemost 93: 676–681.
   PubMed Web of Science ®Google Scholar
• Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I (2002a): Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions. Clin Exp Metastasis 19: 135–144.
   PubMedGoogle Scholar
• Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Reich R (2002b): The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol Cell Endocrinol 187: 39–45.
   PubMed Web of Science ®Google Scholar
• Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, Reich R (2003): Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway? Cancer Metastasis Rev 22: 103–115.
   PubMedGoogle Scholar
• Di Blasio AM, Carniti C, Viganò P, Vignali M (1995): Basic fibroblast growth factor and ovarian cancer. J Steroid Biochem Mol Biol 53: 375–379.
   PubMedGoogle Scholar
• Forbes K, Webb MA, Sehgal I (2003): Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts. Prostate Cancer Prostatic Dis 6: 148–153.
   PubMedGoogle Scholar
• Fujimoto J, Aoki I, Toyoki H, Khatun S, Sato E, Sakaguchi H, Tamaya T (2004): Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers. Oncology 66: 420–428.
   PubMedGoogle Scholar
• Gan Y, Wientjes MG, Au JL (2006): Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors. Pharm Res 23: 1324–1331.
   PubMed Web of Science ®Google Scholar
• Iwasaka C, Tanaka K, Abe M, Sato Y (1996): Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169: 522–531.
   PubMed Web of Science ®Google Scholar
• Kanda K, Ueda M, Futakuchi H, Yamaguchi H, Mori K, Terai Y, Ueki M (2005): Transcriptional expression of the genes implicated in angiogenesis and tumor invasion in cervical carcinomas. Gynecol Oncol 98: 453–461.
   PubMed Web of Science ®Google Scholar
• Kitange G, Shibata S, Tokunaga Y, Yagi N, Yasunaga A, Kishikawa M, Naito S (1999): Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Lab Invest 79: 407–416.
   PubMed Web of Science ®Google Scholar
• Le Page C, Ouellet V, Madore J, Hudson TJ, Tonin PN, Provencher DM, Mes-Masson AM (2006): From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer. Int J Cancer 118: 1750–1758.
   PubMedGoogle Scholar
• Mandriota SJ, Pepper MS (1997): Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 110: 2293–2302.
   PubMed Web of Science ®Google Scholar
• Mori T, Abe T, Wakabayashi Y, Hikawa T, Matsuo K, Yamada Y, Kuwano M, Hori S (2000): Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor. J Neurooncol 46: 115–123.
   PubMedGoogle Scholar
• Pötgens AJ, Westphal HR, de Waal RM, Ruiter DJ (1995): The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol Chem Hoppe Seyler 376: 57–70.
   PubMed Web of Science ®Google Scholar
• Sako A, Kitayama J, Yamaguchi H, Kaisaki S, Suzuki H, Fukatsu K, Fujii S, Nagawa H (2003): Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis. J Surg Res 115: 113–120.
   PubMedGoogle Scholar
• Schmalfeldt B, Prechtel D, Härting K (2001): Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7: 2396–2404.
   PubMed Web of Science ®Google Scholar
• Ueda M, Terai Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Ueki M (2001): Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 82: 162–166.
   PubMedGoogle Scholar
• Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Seiki M, Ishii S, Fujinaga K (1998): The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 77: 128–137.
   PubMed Web of Science ®Google Scholar
• Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ (1998): Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 90: 447–454.
   PubMed Web of Science ®Google Scholar
• Zhao ZS, Zhou JL, Yao GY, Ru GQ, Ma J, Ruan J (2005): Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas. World J Gastroenterol 11: 3227–3233.
   PubMedGoogle Scholar